Terumo Beat Consensus Estimates

Terumo (TRUMY) reported earnings of $0.30 per share on revenue of $1.96 billion for the fiscal first quarter ended June 2026. The consensus earnings estimate was $0.17 per share. The company beat consensus estimates by 76.47% while revenue grew 8.73% on a year-over-year basis.

Terumo Corp is a manufacturer and supplier of pharmaceuticals and medical tools and equipment. Its products include health foods, transfusion and infusion equipment, disposable medical supply, clinical testing systems & artificial organs.